Search Results - "Middleton, Peter G."

Refine Results
  1. 1

    Survival of people with cystic fibrosis in Australia by Ruseckaite, Rasa, Salimi, Farhad, Earnest, Arul, Bell, Scott C., Douglas, Tonia, Frayman, Katherine, Keatley, Lucy, King, Susannah, Kotsimbos, Tom, Middleton, Peter G., Morey, Sue, Mulrennan, Siobhain, Schultz, Andre, Wainwright, Claire, Ward, Nathan, Wark, Peter, Ahern, Susannah

    Published in Scientific reports (17-11-2022)
    “…Survival statistics, estimated using data from national cystic fibrosis (CF) registries, inform the CF community and monitor disease progression. This study…”
    Get full text
    Journal Article
  2. 2

    Cystic fibrosis modulator therapy can reverse cystic bronchiectasis by Middleton, Peter G., Simmonds, Nicholas J.

    Published in Respirology case reports (01-07-2023)
    “…Bronchiectasis is often considered progressive and irreversible, so cases of regression or reversal are an important step in understanding the underlying…”
    Get full text
    Journal Article
  3. 3

    Family planning, pregnancy and birth in women with lung conditions: a worldwide survey by Williams, Clare, Johnson, Barbara, Middleton, Peter G, Backer, Vibeke, Gibson, Peter G, Hollis, Gill, Coleman, Courtney

    Published in ERJ open research (01-10-2021)
    “…Lung diseases can complicate pregnancy, but little is known about the experiences of pregnancy among women living with such diseases. This survey aimed to…”
    Get full text
    Journal Article
  4. 4

    Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study by Harkensee, Christian, Oka, Akira, Onizuka, Makoto, Middleton, Peter G., Inoko, Hidetoshi, Hirayasu, Kouyuki, Kashiwase, Koichi, Yabe, Toshio, Nakaoka, Hirofumi, Gennery, Andrew R., Ando, Kiyoshi, Morishima, Yasuo

    Published in Blood (28-06-2012)
    “…Genetic risk factors contribute to adverse outcome of hematopoietic stem cell transplantation (HSCT). Mismatching of the HLA complex most strongly determines…”
    Get full text
    Journal Article
  5. 5

    Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis by Schultz, Andre, Marsh, Julie A, Saville, Benjamin R, Norman, Richard, Middleton, Peter G, Greville, Hugh W, Bellgard, Matthew I, Berry, Scott M, Snelling, Tom

    Published in Frontiers in pharmacology (28-03-2019)
    “…Cystic fibrosis is a genetic disease typically characterized by progressive lung damage and premature mortality. Pulmonary exacerbations, or flare-ups of the…”
    Get full text
    Journal Article
  6. 6

    Obstructive sleep apnoea and sleep disorders in pregnancy by Middleton, Peter G.

    “…This review provides a summary for obstetricians, midwives, other health professionals and women contemplating pregnancy about the interactions between…”
    Get full text
    Journal Article
  7. 7

    Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions by Fawcett, Laura K, Wakefield, Claire E, Sivam, Sheila, Middleton, Peter G, Wark, Peter, Widger, John, Jaffe, Adam, Waters, Shafagh A

    Published in ERJ open research (01-01-2021)
    “…Patient-oriented research approaches that reflect the needs and priorities of those most affected by health research outcomes improves translation of research…”
    Get full text
    Journal Article
  8. 8

    Intermittent colonisation with Methicillin-Resistant Staphylococcal aureus can be eradicated from the Airways of Adults with Cystic Fibrosis by Ranzenbacher, Lucy, Song, Yang, Merchant, Alison, Middleton, Peter G

    Published in Antibiotics (Basel) (09-08-2019)
    “…The airways of people with cystic fibrosis (CF) are chronically colonised with different pathogens. With recent interest in methicillin-resistant…”
    Get full text
    Journal Article
  9. 9

    The fate of human Langerhans cells in hematopoietic stem cell transplantation by Collin, Matthew P, Hart, Derek N J, Jackson, Graham H, Cook, Gordon, Cavet, James, Mackinnon, Stephen, Middleton, Peter G, Dickinson, Anne M

    Published in The Journal of experimental medicine (23-01-2006)
    “…Langerhans cells (LC) and other antigen-presenting cells are believed to be critical in initiating graft versus host responses that influence the outcome of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Genetic polymorphisms predicting the outcome of bone marrow transplants by Dickinson, Anne M., Middleton, Peter G., Rocha, Vanderson, Gluckman, Eliane, Holler, Ernst

    Published in British journal of haematology (01-12-2004)
    “…Summary Analysis of non‐histocompatibility leucocyte antigen (HLA) functional genomics, together with conventional risk factors in haematopoietic stem cell…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators – an international survey by Nash, Edward F, Middleton, Peter G, Taylor-Cousar, Jennifer L

    Published in Journal of cystic fibrosis (01-07-2020)
    “…As their long-term prognosis improves, women with CF are increasingly choosing to have children, but the safety of CFTR modulators in pregnancy and…”
    Get full text
    Journal Article
  15. 15

    ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases by Middleton, Peter G, Gade, Elisabeth J, Aguilera, Cristina, MacKillop, Lucy, Button, Brenda M, Coleman, Courtney, Johnson, Barbara, Albrechtsen, Charlotte, Edenborough, Frank, Rigau, David, Gibson, Peter G, Backer, Vibeke

    Published in The European respiratory journal (01-02-2020)
    “…This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the…”
    Get full text
    Journal Article
  16. 16

    Long-Term CFTR Modulators and Changes in Hemoglobin by Middleton, Peter G

    Published in Annals of the American Thoracic Society (01-03-2019)
    “…Cystic fibrosis (CF) treatment is being revolutionized by the development of modulators of the CF transmembrane conductance regulator (CFTR) protein. Since the…”
    Get full text
    Journal Article
  17. 17

    Pulmonary disorders in pregnancy: Bronchiectasis, cystic fibrosis, sarcoidosis and interstitial diseases by Haines, Alena J., Middleton, Peter G.

    “…This chapter aims to provide expert guidance to obstetricians, general practitioners, allied health staff and women with lung disease about the interactions…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Occupations and balance during the transition to motherhood with a lifetime chronic illness: A scoping review examining cystic fibrosis, asthma, and Type‐1 diabetes by Haines, Alena Jane, Mackenzie, Lynette, Honey, Anne, Middleton, Peter G.

    Published in Australian occupational therapy journal (01-12-2023)
    “…Introduction Throughout the transition to motherhood, changes are experienced across a woman's physical, mental, social, and occupational self. Maternal…”
    Get full text
    Journal Article
  20. 20

    Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry by Thompson, Cassandra, Middleton, Peter G

    Published in Annals of the American Thoracic Society (01-04-2023)
    “…Thompson and Middleton discuss the retrospective study, Salinas et al, of 92 cystic fibrosis transmembrane conductance regulator (CFTR) variants of interest in…”
    Get full text
    Journal Article